A detailed history of Legal & General Group PLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 7,073 shares of STRO stock, worth $19,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,073
Previous 7,073 -0.0%
Holding current value
$19,450
Previous $24,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.92 - $5.33 $6,169 - $11,262
2,113 Added 42.6%
7,073 $20,000
Q3 2023

Nov 14, 2023

SELL
$3.29 - $4.9 $2,714 - $4,042
-825 Reduced 14.26%
4,960 $17,000
Q2 2023

Aug 14, 2023

BUY
$4.25 - $5.88 $2,715 - $3,757
639 Added 12.42%
5,785 $26,000
Q4 2022

Feb 14, 2023

BUY
$5.41 - $8.08 $2,980 - $4,452
551 Added 11.99%
5,146 $41,000
Q3 2022

Nov 14, 2022

BUY
$5.17 - $7.11 $4,565 - $6,278
883 Added 23.79%
4,595 $26,000
Q2 2022

Aug 22, 2022

SELL
$3.41 - $8.95 $25,772 - $67,644
-7,558 Reduced 67.06%
3,712 $19,000
Q3 2021

Nov 15, 2021

BUY
$16.88 - $22.38 $107,171 - $142,090
6,349 Added 129.02%
11,270 $213,000
Q2 2021

Aug 12, 2021

BUY
$18.03 - $23.82 $27,243 - $35,992
1,511 Added 44.31%
4,921 $92,000
Q1 2021

May 17, 2021

BUY
$20.29 - $27.54 $5,478 - $7,435
270 Added 8.6%
3,410 $78,000
Q4 2020

Feb 12, 2021

BUY
$10.16 - $23.98 $2,062 - $4,867
203 Added 6.91%
3,140 $68,000
Q3 2020

Nov 13, 2020

BUY
$7.44 - $13.15 $2,105 - $3,721
283 Added 10.66%
2,937 $30,000
Q2 2020

Aug 14, 2020

BUY
$7.24 - $11.05 $9,100 - $13,889
1,257 Added 89.98%
2,654 $21,000
Q1 2020

May 14, 2020

SELL
$6.19 - $12.16 $3,107 - $6,104
-502 Reduced 26.43%
1,397 $14,000
Q4 2019

Feb 13, 2020

BUY
$8.15 - $11.39 $652 - $911
80 Added 4.4%
1,899 $21,000
Q2 2019

Aug 14, 2019

BUY
$9.69 - $12.23 $8,062 - $10,175
832 Added 84.3%
1,819 $21,000
Q4 2018

Feb 15, 2019

BUY
$8.69 - $14.85 $8,577 - $14,656
987 New
987 $9,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $143M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.